SUS 📈 Surgical Science Sweden AB - Overview

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0014428512

SUS: Virtual Reality Simulators, Surgical Training, Medical Education

Surgical Science Sweden AB (publ) is a pioneer in the development and marketing of virtual reality simulators for evidence-based medical training, with a global presence spanning Europe, North and South America, Asia, and international markets. The company's product portfolio includes a range of simulators, such as the Angio Mentor for endovascular training, BRONCH Express, a portable version of the BRONCH Mentor simulator, and ARTHRO Mentor for arthroscopic surgery skills acquisition. These simulators are designed to provide medical professionals with realistic and immersive training experiences, allowing them to hone their skills in a risk-free environment.

The company's simulator offerings also include the BRONCH Mentor for optimizing bronchoscopy training, GI Mentor for GI Endoscopy, HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training, and URO Mentor, a virtual reality simulator for endourology training. Additionally, Surgical Science Sweden AB provides the EndoSim, a realistic scope simulator, and FlexVR, a flexible and portable training platform designed to teach basic and advanced skills for robotic surgery. The LAP Mentor provides a wide array of laparoscopic training cases, while the LapSim training system comprises the LapSim Haptic simulator, LapSim essence, and LapSim 360, which provide laparoscopic training, portable and ready-to-use VR simulation, and high-immersion virtual reality training experiences, respectively.

Surgical Science Sweden AB also offers a range of other simulators, including the MentorLearn, an end-to-end educational platform that streamlines simulation course management, and the LapSim ST, a state-of-the-art training system that prepares students for the operating room. The PELVIC Mentor simulator provides anatomy and pelvic exam training, while the Perc Mentor suite is designed for image-guided interventions. The RobotiX Mentor allows surgeons to practice motor and cognitive skills, and the Simball Box combines digitally collected metrics into a powerful training tool. The company also provides the Spine Mentor, a training simulator for minimal invasive spine surgery, TEE Express, designed to teach Trans-Esophageal Echocardiography procedure, TraumaVR, an ultimate mix of manikin and VR simulation, and Ultrasound Mentor for ultrasound training with multiple medical specialties.

With a history dating back to 1997, Surgical Science Sweden AB is headquartered in Gothenburg, Sweden, and is listed on the stock exchange with the ISIN SE0014428512, classified as a common stock under the GICS Sub Industry: Health Care Technology. The company's commitment to innovation and customer satisfaction has enabled it to establish a strong presence in the global medical training market, with a website available at https://www.surgicalscience.com, providing access to its range of products and services.

Additional Sources for SUS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

SUS Stock Overview

Market Cap in USD 696m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception

SUS Stock Ratings

Growth 5y 27.2%
Fundamental 33.3%
Dividend 18.2%
Rel. Strength Industry -579
Analysts -
Fair Price Momentum 147.28 SEK
Fair Price DCF 37.01 SEK

SUS Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 100.0%

SUS Growth Ratios

Growth Correlation 3m 81.4%
Growth Correlation 12m -62.9%
Growth Correlation 5y 37.8%
CAGR 5y 14.19%
CAGR/Mean DD 5y 0.40
Sharpe Ratio 12m -0.10
Alpha -34.82
Beta 0.91
Volatility 48.37%
Current Volume 108k
Average Volume 20d 91.3k
What is the price of SUS stocks?
As of December 22, 2024, the stock is trading at SEK 161.50 with a total of 108,004 shares traded.
Over the past week, the price has changed by +4.90%, over one month by +10.24%, over three months by +29.33% and over the past year by -11.17%.
Is Surgical Science Sweden AB a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Surgical Science Sweden AB is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 33.32 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SUS as of December 2024 is 147.28. This means that SUS is currently overvalued and has a potential downside of -8.8%.
Is SUS a buy, sell or hold?
Surgical Science Sweden AB has no consensus analysts rating.
What are the forecast for SUS stock price target?
According to ValueRays Forecast Model, SUS Surgical Science Sweden AB will be worth about 163.3 in December 2025. The stock is currently trading at 161.50. This means that the stock has a potential upside of +1.13%.
Issuer Forecast Upside
Wallstreet Target Price 192.2 19%
Analysts Target Price - -
ValueRay Target Price 163.3 1.1%